Abbott Ventures (AVI) is a venture capital firm that primarily invests in emerging medical technology companies. AVI targets various stages of development, with a particular interest in development-stage companies within the medical devices, drug/device combinations, diagnostics, and unique drug delivery technologies sectors. The firm typically engages in Series A, B, and C funding rounds, reflecting its focus on companies poised for significant growth and innovation in the healthcare industry.
Notable portfolio companies include Bigfoot Biomedical, Howard University, Hydra Biosciences, Ovalis, and Setpoint Medical. AVI's investment philosophy centers on fostering long-term strategic growth options for Abbott Laboratories, leveraging its deep expertise in the healthcare sector. The firm offers unique value-add services to its portfolio companies, including strategic guidance and access to Abbott's extensive resources and networks. Key decision-makers at AVI bring a wealth of experience from their affiliations with leading healthcare and medical device companies.